TORONTO, July 7, 2021 /CNW/ - Ken D'Entremont, Chief
Executive Officer, Medexus Pharmaceuticals Inc., ("Medexus" or the
"Company") (TSX: MDP), and his team joined Daniel Lubienietzky,
Manager, Life Sciences, TMX Group, to celebrate the Company's new
listing on Toronto Stock Exchange and open the market.
Medexus Pharmaceuticals Inc. is a leading innovative and rare
disease pharmaceutical company with a focus on the therapeutic
areas of hematology, transplant, auto-immune disease, specialty
oncology, allergy, and pediatric diseases. Medexus provides
innovative and market-leading brands to improve the lives of
patients and provide important options to healthcare professionals.
For more information please visit: https://www.medexus.com/.
For Market Openings: Media may pick up a feed
from the TOC (television operations centre) for all market open
ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is
produced at the TMX Broadcast Centre and sent live to the TOC. To
pick up the feed via the Dejero network, please contact
avservices@tmx.com. The client feature video will begin playing on
the TMX media wall at approximately 9:27
a.m. ET and the markets will open with the sound of a siren
at 9:30 a.m. ET
Date: Wednesday July
7, 2021
Time: 9:00am -
9:30am
Place: Virtually Broadcast
SOURCE Toronto Stock Exchange